PRNP E146G突变遗传的病:具有独特的临床,病理和流体生物标记特征
Thomas Coysh1,2, Zane Jaunmuktane3, Laszlo L P Hosszu1
1MRC Prion Unit at UCL, UCL Institute of Prion Diseases, 33 Cleveland Street, London, W1W 7FF, UK.
Journal of neurology
|March 29, 2025
概括
一种新型的PRNP E146G突变导致具有明显临床和生物标记特征的遗传性性疾病 (IPD). 这一发现有助于识别这种罕见的神经退行性疾病.
科学领域:
- 神经遗传学 神经遗传学
- 神经病理学神经病理学
- 分子生物学分子生物学
背景情况:
- 遗传性性疾病 (IPD) 是一种罕见的,致命的神经退行性疾病.
- 蛋白基因 (PRNP) 的突变导致IPD,导致不同的临床表现.
- 准确的IPD诊断和表征对于了解疾病机制至关重要.
研究的目的:
- 描述一种与一种独特形式的遗传性病相关的新型PRNP E146G突变.
- 详细介绍这种突变患者的临床,神经成像和液体生物标记特征.
- 为了将表型与现有的IPD分类进行比较,例如Gerstmann-Sträussler-Scheinker疾病.
主要方法:
- 一个带有新型PRNP突变的三代家族的临床表型.
- 神经成像 (MRI) 分析以确定结构性大脑变化.
- 脑脊液 (CSF) 和血生物标志物分析,包括S100B,tau,GFAP,NFL,14-3-3和RT-QuIC.
- 尸检后的神经病理学检查,包括PrP粉样蛋白斑块评估和免疫血栓检查.
主要成果:
- 在一个IPD家族中发现了一种新的PRNP E146G突变.
- 患者呈现缓慢进展的肌痛性关节炎,突出的肌肉性关节炎和步态无力症,早期认知能力下降最小.
- 独特的液体生物标志物概况:中枢神经液S100B升高,中等升高的中枢神经液tau,阴性NFL/14-3-3/RT-QuIC,显著升高的血GFAP与正常的血NFL.
- 尸检后的发现包括小脑缩,广泛的PrP粉样板和低分子量蛋白酶耐药PrP碎片.
结论:
- PRNP E146G突变定义了一个独特的遗传性病亚型.
- 独特的临床和生物标志物概况可以帮助早期识别.
- 这种IPD变异扩大了Gerstmann-Sträussler-Scheinker病的谱,突出了PRNP突变的表型多样性.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


